Krzysztof Tomasiewicz

Prevalence and predictors of HCV infection among hospitalized psychiatric patients in Poland

Krzysztof Tomasiewicz, Piotr Gałecki, Jerzy Jaroszewicz, Jolanta Opoka et autres

pl, ch, gb, au (code pays fourni par la source)

Delineating RSV‐A and RSV‐B: Epidemiological Patterns, Diagnostics, Clinical Severity, and Preventive Approaches

Piotr Rzymski, Barbara Poniedziałek, Dorota Zarębska‐Michaluk, Lidia Brydak et autres

pl (code pays fourni par la source)

Correction: Overcoming the barriers in the screening, diagnosis, and follow-up of patients with metabolic dysfunction–associated steatotic liver disease (MASLD) and metabolic dysfunction–associated steatohepatitis (MASH)

Roberto Vettor, Maria Letizia Petroni, Idit Dotan, Gadi Lalazar et autres

it, il, cz, Afrique du Sud, sa, ae, hu, pl, gr, ro, us (code pays fourni par la source)

WED-577 Up to 24 months durability of functional cure in response to bepirovirsen plus Peg-IFN sequential therapy in B-Together responders: results from the B-Sure study

Carla Coffin, Pietro Andreone, Joaquin Cabezas, Stuart C Gordon et autres

Overcoming the barriers in the screening, diagnosis, and follow-up of patients with metabolic dysfunction–associated steatotic liver disease (MASLD) and metabolic dysfunction–associated steatohepatitis (MASH)

Roberto Vettor, Maria Letizia Petroni, Idit Dotan, Gadi Lalazar et autres

it, il, cz, Afrique du Sud, sa, ae, hu, pl, gr, ro, us (code pays fourni par la source)

Influence of antiviral treatment in hepatitis C patients on metabolism and fibrosis process

Malwina Jędrysik, Krzysztof Tomasiewicz, Beata Chełstowska, Magdalena Tudrujek-Zdunek et autres

pl (code pays fourni par la source)

Clinical characteristics of hospitalized patients with hepatitis E virus infection in Poland: a multi-centre retrospective study

Anna Parfieniuk‐Kowerda, Jerzy Jaroszewicz, Piotr Grabarczyk, Dorota Zarębska‐Michaluk et autres

pl (code pays fourni par la source)

Predictors of Severe Outcomes in COVID-19: Evidence from Real-World Multicenter Retrospective Study (2020–2024)

Małgorzata Wajdowicz, Krystyna Dobrowolska, Kinga Brzdęk, Jakub Janczura et autres

pl (code pays fourni par la source)

Recent advances in the treatment of chronic liver diseases: focus on MASLD/MASH-related fibrosis

Malwina Jędrysik, Beata Chełstowska, Krzysztof Tomasiewicz, Filip M. Szymański

pl (code pays fourni par la source)

Recommendations for treatment of viral hepatitis B in 2026 by the Polish Group of Experts for HBV

Robert Flisiak, Jerzy Jaroszewicz, Piotr Małkowski, Małgorzata Pawłowska et autres

pl (code pays fourni par la source)

Management of HCV-infected patients after successful direct-acting antiviral therapy

Michał Brzdęk, Robert Flisiak, Krzysztof Tomasiewicz, Dorota Zarębska-Michaluk

pl (code pays fourni par la source)

Szczepienia ochronne u dorosłych chorych na nowotwory hematologiczne, u chorych z asplenią oraz chorych na nocną napadową hemoglobinurię — zalecenia PTHiT i Sekcji do spraw Zakażeń PALG

Iwona Hus, Agnieszka Piekarska, Katarzyna Brzeźniakiewicz‐Janus, Krzysztof Giannopoulos et autres

pl (code pays fourni par la source)